UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009660
Receipt number R000011039
Scientific Title A Prospective Non-randomized Multicenter Study to Demonstrate the Clinical Validity of the Intracardiac Impedance (ICI) Measurements by Comparing the ICI Values with Clinical Markers which are Relevant for Efficient Therapy Management of Heart Failure Patient
Date of disclosure of the study information 2013/01/01
Last modified on 2015/07/08 17:17:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective Non-randomized Multicenter Study to Demonstrate the Clinical Validity of the Intracardiac Impedance (ICI) Measurements by Comparing the ICI Values with Clinical Markers which are Relevant for Efficient Therapy Management of Heart Failure Patient

Acronym

DETECT-ICI

Scientific Title

A Prospective Non-randomized Multicenter Study to Demonstrate the Clinical Validity of the Intracardiac Impedance (ICI) Measurements by Comparing the ICI Values with Clinical Markers which are Relevant for Efficient Therapy Management of Heart Failure Patient

Scientific Title:Acronym

DETECT-ICI

Region

Japan


Condition

Condition

Heart Failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of the study is to demonstrate the clinical validity of the Intracardiac Impedance (ICI) measurements by comparing the ICI values with clinical markers which are relevant for an fficient therapy management of heart failure patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The purpose of the primary endpoint 1 is the evaluation of the correlation between the end-systolic impedance (ESZ) assessed by the intracardiac impedance measurement and the left ventricular end-systolic volume (LVESV) assessed by echo 2 dimensional biplane Simpson's method.

Key secondary outcomes

*Identification of a predictive signal pattern of the intracardiac impedance for acute decompensation of heart failure

*Evaluate the correlation between intracardiac impedance and the expected 1-year survival period calculated by the Seattle Heart Failure score

*Evaluate the correlation between stroke impedance assessed by the intracardiac impedance measurement and stroke volume assessed by echocardiography

*Evaluate the correlation between stroke impedance assessed by the intracardiac impedance measurement and the blood concentration of the natriuretic peptide BNP


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

*Patient signed patient informed consent form.
*Patient has a standard indication for CRT-D therapy.
*Patient is implanted a new bipolar LV lead with a tip ring distance of at least *Patient is implanted a true bipolar RV shock lead
*Patient accepts Home Monitoring concept and has sufficient 3 G/L-LINE net
*Patient is able to attend to the planned *Patient has legal capacity and ability to consent.

Key exclusion criteria

*Patient has a standard contraindication for CRT-D implantation.
*Permanent AF and contraindication to be programmed to non-DDD mode (DDI or VVI)
*Patient suffering from aortic valve stenosis, severe aortic insufficiency, or aortic valve prosthesis
*Age < 20 years
*Pregnant or breast-feeding woman
*Cardiac surgery within previous 3 months or planned at time of inclusion
*Life expectancy of less than 12 months due to any condition
*Chronic renal dialysis
*Participating in a clinical study of an investigational cardiac drug or device that includes an active treatment arm

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Morio Shoda

Organization

Tokyo Women's Medical University

Division name

Department of Cardiology

Zip code


Address

8-1 Kawata-cho, Shinjuku, Tokyo, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Kazuomi Tanaka

Organization

Biotronik Japan

Division name

Clinical Affairs

Zip code


Address


TEL

03-3473-7478

Homepage URL


Email



Sponsor or person

Institute

Biotronik Japan

Institute

Department

Personal name



Funding Source

Organization

Biotronik Japan

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2012 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 12 Month 01 Day

Last follow-up date

2016 Year 06 Month 30 Day

Date of closure to data entry

2016 Year 09 Month 30 Day

Date trial data considered complete

2016 Year 12 Month 31 Day

Date analysis concluded

2017 Year 07 Month 31 Day


Other

Other related information

Measurement of intracardiac impedance


Management information

Registered date

2012 Year 12 Month 28 Day

Last modified on

2015 Year 07 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011039


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name